GSK plc insider trades
GSK plc has filed 5 Form 4s with the SEC that we hold, for Wave Life Sciences, Inc. (WVE) (10% owner), CVRx, Inc. (CVRX) (10% owner) and Theravance Biopharma, Inc. (TBPH) (Reporting owner). Across all of them we count 4 purchases worth $71.7M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($27.9M) and 0 sales ($0). The largest single trade was a purchase of 1,470,000 shares of Wave Life Sciences, Inc. worth $27.9M, dated 2025-12-11. The first filing on our record is dated 2021-07-06 and the latest 2025-12-15.
Wave Life Sciences, Inc. (WVE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-07 | P, purchase reported on Form 4 | 3,300,000 | $16.5M | 2024-01-30 |
| 2024-09-27 | P, purchase reported on Form 4 | 2,791,930 | $22.3M | 2024-10-01 |
| 2025-12-11 | P, purchase reported on Form 4 | 1,470,000 | $27.9M | 2025-12-15 |
CVRx, Inc. (CVRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-02 | P, purchase reported on Form 4 | 275,000 | $5.0M | 2021-07-06 |
Theravance Biopharma, Inc. (TBPH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1131399) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms